CA2678706C - Composition for combating epistaxis - Google Patents

Composition for combating epistaxis Download PDF

Info

Publication number
CA2678706C
CA2678706C CA2678706A CA2678706A CA2678706C CA 2678706 C CA2678706 C CA 2678706C CA 2678706 A CA2678706 A CA 2678706A CA 2678706 A CA2678706 A CA 2678706A CA 2678706 C CA2678706 C CA 2678706C
Authority
CA
Canada
Prior art keywords
gel
composition
epistaxis
concentration
per litre
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2678706A
Other languages
English (en)
French (fr)
Other versions
CA2678706A1 (en
Inventor
Bjoern Petruson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacure Health Care AB
Original Assignee
Pharmacure Health Care AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacure Health Care AB filed Critical Pharmacure Health Care AB
Publication of CA2678706A1 publication Critical patent/CA2678706A1/en
Application granted granted Critical
Publication of CA2678706C publication Critical patent/CA2678706C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2678706A 2007-02-21 2008-02-21 Composition for combating epistaxis Active CA2678706C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0703377.2 2007-02-21
GB0703377A GB2447012B (en) 2007-02-21 2007-02-21 Composition for combating epistaxis
PCT/GB2008/000608 WO2008102150A2 (en) 2007-02-21 2008-02-21 Composition for combating epistaxis

Publications (2)

Publication Number Publication Date
CA2678706A1 CA2678706A1 (en) 2008-08-28
CA2678706C true CA2678706C (en) 2014-11-18

Family

ID=37909023

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2678706A Active CA2678706C (en) 2007-02-21 2008-02-21 Composition for combating epistaxis

Country Status (19)

Country Link
US (1) US9138406B2 (enExample)
EP (1) EP2117502B1 (enExample)
JP (1) JP2010519285A (enExample)
KR (1) KR20090130001A (enExample)
CN (1) CN101677940B (enExample)
AU (1) AU2008217608B2 (enExample)
BR (1) BRPI0807732B8 (enExample)
CA (1) CA2678706C (enExample)
DK (1) DK2117502T3 (enExample)
ES (1) ES2606947T3 (enExample)
GB (1) GB2447012B (enExample)
HR (1) HRP20161626T1 (enExample)
HU (1) HUE031199T2 (enExample)
IL (1) IL200277A0 (enExample)
PL (1) PL2117502T3 (enExample)
PT (1) PT2117502T (enExample)
RU (1) RU2473327C2 (enExample)
WO (1) WO2008102150A2 (enExample)
ZA (1) ZA200905519B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
USD993736S1 (en) 2023-05-17 2023-08-01 Line Work Bucket Products, LLC Auger and socket holder
WO2026030821A1 (en) * 2024-08-07 2026-02-12 Conlin Anne Nasal formulations for non-invasive nasal delivery

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363319A (en) * 1980-06-30 1982-12-14 Applied Medical Devices, Inc. Ready-to-use bandage incorporating a coagulant composition and method of preparing same
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
AU2793292A (en) * 1991-10-11 1993-05-03 Novo Nordisk A/S Hemostatic composition for local hemostasis
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5928611A (en) * 1995-06-07 1999-07-27 Closure Medical Corporation Impregnated applicator tip
US6365131B1 (en) * 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
WO2001000218A1 (en) * 1999-06-30 2001-01-04 Scott Cordray Nasal spray having dead sea salts
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
RU2156612C1 (ru) * 2000-03-13 2000-09-27 Волков Александр Григорьевич Способ остановки носового кровотечения
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7303759B2 (en) * 2001-06-22 2007-12-04 The United States Of America As Represented By The Secretary Of The Army Compositions and methods for reducing blood and fluid loss from open wounds
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
RU2290937C1 (ru) * 2005-10-03 2007-01-10 Владислав Владимирович Петров Способ остановки носового кровотечения
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis

Also Published As

Publication number Publication date
CN101677940B (zh) 2014-02-19
PT2117502T (pt) 2016-12-13
IL200277A0 (en) 2010-04-29
US20100119472A1 (en) 2010-05-13
HUE031199T2 (en) 2017-07-28
JP2010519285A (ja) 2010-06-03
KR20090130001A (ko) 2009-12-17
ZA200905519B (en) 2010-10-27
CN101677940A (zh) 2010-03-24
RU2009134086A (ru) 2011-03-27
EP2117502B1 (en) 2016-11-09
DK2117502T3 (en) 2017-01-23
CA2678706A1 (en) 2008-08-28
ES2606947T3 (es) 2017-03-28
GB0703377D0 (en) 2007-03-28
EP2117502A2 (en) 2009-11-18
BRPI0807732A2 (pt) 2014-06-03
AU2008217608A1 (en) 2008-08-28
RU2473327C2 (ru) 2013-01-27
HRP20161626T1 (hr) 2017-03-10
BRPI0807732B1 (pt) 2020-08-04
PL2117502T3 (pl) 2017-08-31
GB2447012B (en) 2011-03-16
WO2008102150A2 (en) 2008-08-28
AU2008217608B2 (en) 2013-01-10
GB2447012A (en) 2008-09-03
BRPI0807732B8 (pt) 2021-05-25
WO2008102150A3 (en) 2009-04-30
US9138406B2 (en) 2015-09-22

Similar Documents

Publication Publication Date Title
US5102666A (en) Calcium polycarbophil controlled release composition and method
CA2312558C (en) Collagen containing tissue adhesive
US7303759B2 (en) Compositions and methods for reducing blood and fluid loss from open wounds
KR102350526B1 (ko) 응집성이 개선된 창상피복재 조성물의 제조 방법
JP2007512410A (ja) 皮膚接着性ヒドロゲル
EP2520279A1 (en) Thermoreversible gel pharamaceutical compositions for odontoiatric use
EP0497956B1 (en) Controlled release formulations
CN107184949A (zh) 一种表皮创伤修复软膏及其制备方法
EP2117502B1 (en) Composition for combating epistaxis
US9433644B2 (en) Formulations and methods for treating oral inflammation, injury, or pain
JP6595717B2 (ja) 骨関節炎治療のための親水化されたスルファサラジンおよびヒアルロン酸を含む組成物およびその製造方法
EP3233092A1 (en) Formulations of calcium and phosphate for oral inflammation
US20230158051A1 (en) Pharmaceutical paste formulations for site specific application
EP3501507A1 (en) Macrogols for application to the mucosa, and therapeutic uses thereof
US5661137A (en) Antacid pharmaceutical composition in the form of a suspension based on sucralfate gel
TW202600143A (zh) 用於治療糖尿病性潰瘍的具幾丁聚醣及水解膠原蛋白之梭鏈孢酸膠及製作其之製程
WO2025010400A2 (en) Compositions and methods for improved treatment of skin wounds
CN113679848A (zh) 一种牙科基质辅料及其制备方法
US20240325503A1 (en) Wound healing and tissue repair composition and method using low molecular weight collagen and bioactive glass
JP2014091740A (ja) グリセリン浣腸剤

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241223

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241223

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241223

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251222

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251222